The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Evidence · Journal club · continued

Journal club: STEP 4 and what a withdrawal design can prove — one year on posts 31–60

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1.

JP
j.petrovTL23 Feb 2025 · edited#31

Taking post #28 at face value and following it one step further.

What I would check first on STEP 4 is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph.

9 likes 18mo
CR
compounding_ruthTL4Pharmacist6 Feb 2025#32

Quietly grateful for the plain phrasing. Not every thread gets that.

21 likes 18mo
FK
f.kimaniTL29 Feb 2025#33
j.petrov, post #31: Taking post #28 at face value and following it one step further. What I would check first on STEP 4 is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph. Go to post

The baseline characteristics table is the single most useful page for the questions that get asked here, because it tells you who the result applies to.

0 likes in reply to #31 18mo
TV
t.vasquezTL4 Moderator11 Feb 2025#34

Practical experience of STEP 4, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it interpretable.

1 like 18mo
MR
m.rasmussenTL214 Feb 2025#35

This follows post #33 rather than contradicting it.

STEP 4: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.

6 likes 17mo
ZO
z.onwukaTL217 Feb 2025#36
h.nwosu, post #26: Acknowledging rather than arguing. The reasoning holds as far as I can follow it. Go to post

A session that ends with a list of what remains unresolved is more useful than one that ends with a verdict. The unresolved list is what feeds the next reading.

15 likes in reply to #26 17mo
CD
c.dahlbergTL220 Feb 2025#37

My understanding of STEP 4 is a few years old and may have been superseded. If it has been, I would genuinely like to know rather than keep repeating it.

30 likes 17mo
JB
j.baptistaTL223 Feb 2025#38

An observation about STEP 4 that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public than private.

0 likes 17mo
DP
d.petrescuTL225 Feb 2025#39

That is clearer than the version I had in my head. Thank you.

20 likes 17mo
IC
i.coelhoTL228 Feb 2025 · edited#40

Reading order that works for these sessions: registry entry, methods, baseline table, primary result, then abstract last. Reading the abstract first anchors everything that follows.

I am aware this is the third time this month I have made this point.

0 likes 17mo
IT
impurity_tableTL3Analytical chemist3 Mar 2025 · edited#41
v.okonkwo, post #22: Taking post #21 at face value and following it one step further. Where I have landed on STEP 4, having got it wrong once in public: the direction is clear, the magnitude is not, and anyone quoting a precise magnitude has borrowed it from somewhere that did not measure it. Go to post

I had written a reply contradicting post #40 and deleted it. Here is what survived.

STEP 4 has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that here yet.

2 likes in reply to #22 17mo
HD
h.delgadoTL26 Mar 2025#42

The documentation on STEP 4 is better than this thread and I say that as someone who has posted in the thread.

0 likes 17mo
CR
compounding_ruthTL4Pharmacist8 Mar 2025#43

The summary that goes to the digest should say what the paper establishes, what it does not, and one thing the group could not settle. Three paragraphs, no more.

The variance between people here is larger than the effect being discussed.

21 likes 17mo
NL
n.laurentTL211 Mar 2025#44

Picking up post #43: that is the part I would want checked first.

STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially larger than anything previously achieved pharmacologically.

9 likes 17mo
TV
t.vasquezTL4 Moderator14 Mar 2025#45
y.adebayo, post #19: Understood. Thank you for being specific about the limits of it. Go to post

Coming back to post #43, because the follow-up matters more than the original answer.

I have three months of notes on STEP 4 and the honest summary is that the trend is real and the week-to-week numbers are noise. I nearly drew the opposite conclusion from the first fortnight.

1 like in reply to #19 16mo
VS
v.sjobergTL217 Mar 2025#46

Post #43 is right about the mechanism and I think understates the practical bit.

A conflict-of-interest statement is worth reading aloud and is worth very little as a predictor. Design quality is what to spend the session on.

0 likes 16mo
SC
so.cardosoTL219 Mar 2025#47

Thank you — that answers what I came here to find out.

15 likes 16mo
SD
s.dziedzicTL222 Mar 2025#48

The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.

Noting that I have skin in this question and have tried to discount for it.

5 likes 16mo
DT
dexa_twice_yearlyTL3Regular24 Mar 2025#49
z.onwuka, post #36: A session that ends with a list of what remains unresolved is more useful than one that ends with a verdict. The unresolved list is what feeds the next reading. Go to post

Bringing the previous paper on the same question makes the session much better and doubles the preparation. Worth doing every third session rather than every one.

The number is defensible. The precision I gave it is not.

0 likes in reply to #36 16mo
IB
i.balogunTL227 Mar 2025 · edited#50
h.nwosu, post #26: Acknowledging rather than arguing. The reasoning holds as far as I can follow it. Go to post

Two sentences on STEP 4 and then I will stop, because the rest is speculation and the thread is better without mine.

What is documented is narrow. What is inferred from it is broad. The gap between them is where every argument here lives.

30 likes in reply to #26 16mo
AA
a.aguirreTL230 Mar 2025#51
t.vasquez, post #34: Practical experience of STEP 4, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it interpretable. Go to post

Having read the whole STEP 4 thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby one instead.

2 likes in reply to #34 16mo
HS
hana.satoTL4 Moderator1 Apr 2025 · edited#52

Post #48 describes the usual case. This is about the unusual one.

Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later.

Flagging that the sources on this are thinner than the confidence in the thread suggests.

8 likes 16mo
JA
j.asanteTL24 Apr 2025#53

The most common failure mode is spending fifty minutes on the effect size and ten on the population. Reversing that ratio would improve most sessions.

26 likes 16mo
PI
p.iyer_pharmdTL3Pharmacist7 Apr 2025#54

Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that question? (3) Was the population sufficiently similar to your population to apply the results? (4) What was the absolute effect, not just the relative one? (5) What are the two strongest criticisms available?

The strength of my opinion here exceeds the strength of my evidence.

0 likes 16mo
HK
h.karlsenTL29 Apr 2025#55
j.petrov, post #31: Taking post #28 at face value and following it one step further. What I would check first on STEP 4 is whether the thing being measured moved or whether the way of measuring it moved. Those look identical in a graph. Go to post

Thank you for taking the time. That was more work than a reply usually is.

4 likes in reply to #31 16mo
CA
c.adebayoTL212 Apr 2025#56

STEP 4 looks different depending on whether you are reading the primary literature or the summaries of it, and the difference is not in our favour.

13 likes 16mo
ZY
z.yildizTL214 Apr 2025#57

Post #54 is the version of this I will quote in future. One addition.

Small methodological point on STEP 4: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to anyone.

0 likes 15mo
VF
v.fontaineTL217 Apr 2025#58
SB
s.balogunTL219 Apr 2025#59

A session that ends with a list of what remains unresolved is more useful than one that ends with a verdict. The unresolved list is what feeds the next reading.

7 likes 15mo
TP
tracked_parcelTL2Regular22 Apr 2025#60

An hour is enough for one paper read properly and not enough for two read partly. The temptation is always to add the second.

18 likes 15mo